Fake news about the coronavirus can do real harm. Polygraph.info is spotlighting fact-checks from other reliable sources here.
Philippine President Rodrigo Duterte: Gasoline can be used as a disinfectant against SARS-CoV-2, the virus that causes COVID-19.

False

Claim that the U.S. Centers for Disease Control and Prevention (CDC) “quietly updated” its COVID-19 data "to admit that only 6%" of all the U.S. deaths recorded actually died from the virus.

False
Around the world, students are returning to school as countries experiment with new educational models and social distancing protocols to prevent the spread of COVID-19.
-- Time, September 2
wades through the literature on the new coronavirus — and summarizes key papers as they appear.
-- Nature, September 1
They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
-- Reuters, August 31
It’s possible that these early cases of reinfection are outliers and have features that won’t apply to the tens of millions of other people who have already shaken off Covid-19.
-- Stat, August 28
It likely provides protection for both.
-- Associated Press, August 27
In many infections, the immune system builds so-called germinal centers in the spleen or lymph nodes to train cells that make antibodies, but the structures fail to develop in some COVID-19 cases.
-- Science, August 25
COVID-19 could be a turning point in climate activism—but only if we play it right.
-- The Walrus. August 24
In 2012, six people at the Mojiang mine, in Yunnan province, experienced a pneumonia-like illness after removing bat feces in their area. Overall, three of the men had died after experiencing fever, dry cough, and other symptoms also typical in COVID-19 patients.
-- News-Medical.Net, August 17
The immune system is no wimp. When pathogens cause illness, it kicks into high gear. Cells work together to tag, kill and gobble up invaders as they fight the infection.
-- Stat, May 5
Eight ways in which scientists hope to provide immunity to SARS-CoV-2.
-- Nature, April 28





